RedHawk Partners With Pelican Engineering LLC for GMP Manufacturing Oversight


Reading time ( words)

RedHawk Holdings Corp., a diversified holding company engaged in sales and distribution of medical devices, branded generic pharmaceutical drugs, commercial real estate investment and leasing, point of entry full-body security systems, and specialized financial services, announced today that RedHawk Research & Development LLC, a wholly-owned subsidiary of the Company, has agreed to partner with Louisiana-based Pelican Engineering LLC ("Pelican") for the supervision of the Company's quality assurance and future research and development programs.

Pelican is a full-service electronics engineering design firm that provides engineering services and component manufacturing in all aspects of the electrical, electronics, and computer engineering disciplines. Primarily focused on embedded printed circuit board hardware and software development, Pelican is capable of in-house engineering, design, manufacturing, and turn-key delivery of high-quality embedded systems.

Pelican was instrumental in the redesign of the SANDD Pro™ as well as the new printed circuit boards used in the SANDD mini – HP™ and the SANDD mini – FR™. Separately, Pelican is also expected to lead the development and redesign of "Centri", the Company's controlled entry security system, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner.

In June 2019, the Company announced the transition and ongoing maintenance of its current FDA-approved quality management system to the higher and more stringent international medical device standard, ISO 13485:2016. The Company believes it is now near completion of this previously announced quality management transition and has now partnered with Pelican to develop and supervise the quality assurances testing believed necessary to maintain adherence to the stringent standards of ISO 13485:2016.

ISO 13485:2016 specifies global requirements for a quality management system where an organization must demonstrate its ability, and the ability of its suppliers, to provide medical devices and related services that consistently meet customer and applicable international regulatory requirements. ISO 13485 was specifically developed with the objective of harmonizing medical device regulatory requirements for quality management systems in major markets around the world including the United States, Europe, Canada, Japan and Australia. ISO 13485 meets, or exceeds, all U.S. Food and Drug Administration Quality System Regulations Standard 21 CFR 820 which was established in 1978 to outline Current Good Manufacturing Practices (GMP) in the United States.

Commenting on the partnership with Pelican, G. Darcy Klug, RedHawk's Chairman and Interim Chief Executive Officer, said "We believe the previously announced partnership with the CKRX Enterprise sales organization positions us well for the commercial launch of our SANDD™ line of needle incineration products.Our next marketing focus is the consumer launch of the SANDD™ line of needle incineration devices. To properly position RedHawk for the consumer market, we believe we need to obtain Durable Medical Equipment ("DME") Accreditation of our quality assurance program. The transition of our quality assurance program to ISO 13485:2016 and the completion of the quality assurance partnership with Pelican is the next step in preparing for DME Accreditation."

"DME Accreditation is necessary for RedHawk to obtain a DME supplier license," continued Mr. Klug. "With Pelican's support, we believe that we are now positioned to seek the necessary DME Accreditation approvals. With DME Accreditation, we anticipate our customers will be eligible to receive Medicare, Medicaid or insurance company reimbursement for the purchase of our SANDD™ line of needle incineration devices. Obtaining these approvals would be a major milestone on the path for RedHawk to continue executing on its business model."

Share

Print


Suggested Items

'Eyes' for the Autopilot

07/05/2019 | TUM
Automatic landings have long been standard procedure for commercial aircraft. While major airports have the infrastructure necessary to ensure the safe navigation of the aircraft, this is usually not the case at smaller airports.

DARPA Tests Advanced Chemical Sensors

05/03/2019 | DARPA
DARPA’s SIGMA program, which began in 2014, has demonstrated a city-scale capability for detecting radiological and nuclear threats that is now being operationally deployed.

Researchers Selected to Develop Novel Approaches to Lifelong Machine Learning

05/07/2018 | DARPA
Machine learning (ML) and artificial intelligence (AI) systems have significantly advanced in recent years. However, they are currently limited to executing only those tasks they are specifically designed to perform and are unable to adapt when encountering situations outside their programming or training.



Copyright © 2020 I-Connect007. All rights reserved.